AKAkihiko Kameyama

Akihiko Kameyama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Akihiko Kameyama has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Identification and characterization of xyloglucan-degradation related α-1,2-l-fucosidase in Aspergillus oryzae

    by Naoki Shimada, Akihiko Kameyama, Masahiro Watanabe, Takehiko Sahara, Tomohiko Matsuzawa


  • Preparation of Soluble Mucin Solutions from the Salivary Glands

    by Takanori Sugiura, Akihiko Kameyama

    Studying salivary gland mucins is important for elucidating the pathogenesis of salivary gland diseases, including tumors and xerostomia, and developing diagnostic methods for them. Classic methods for isolating mucins from salivary glands require sacrificing several animals to obtain sufficient quantities of mucin and are time-consuming. Supported molecular matrix electrophoresis (SMME) was used to characterize mucins and their glycans. With this method, mucins can be analyzed within 2 days using less than 100 mg of tissue and without using expensive equipment, such as an ultracentrifuge. This chapter describes a method for preparing mucin solutions for SMME analysis of salivary gland mucins. Key words Mucin O-linked glycan Submaxillary gland Sublingual gland Submandibular gland Ethanol precipitation Supported molecular matrix electrophoresis

  • Supported Molecular Matrix Electrophoresis

    by Akihiko Kameyama

    Distinct bands of mucins cannot be banded using a gel electrophoresis based on a molecular sieving effect due to their very large molecular weight and remarkable diversity in glycosylation. In contrast, membrane electrophoresis can separate mucins as round bands. Here, we present an analysis of mucin separation via membrane electrophoresis using a porous polyvinylidene difluoride membrane, which is highly stable against chemical modifications and various organic solvents. The separated mucins can not only be stained with dyes but also with antibodies and lectins, and glycans can be released from the excised bands and analyzed. Key words Polyvinylidene difluoride membrane Membrane electrophoresis Polyvinylalcohol Glycans Alcian blue Lectin


  • Eliminative Oximation of O-Glycans from Mucins

    by Akihiko Kameyama

    The large variety and high concentration of O-glycans are characteristic properties of mucins and play a crucial role in their unique functions. Analyzing the O-glycans of mucins is essential for investigating the functions of mucins. Eliminative oximation is an aqueous reaction that can be used to obtain O-glycan oximes from mucins. Using diazabicyclo undec-7ene (DBU) as a base, an organic superbase that can be removed with an organic solvent during solid-phase extraction, and adding hydroxylamine to the reaction mixture in advance, the O-glycans released from the mucin are immediately converted to the corresponding glycan oximes. The glycan oxime can then be fluorescently labeled with a fluorescent labeling reagent and 2-picoline borane via reductive amination. O-glycans that have been fluorescently labeled can be analyzed using conventional HPLC techniques. Key words Mucin O-linked glycan Glycan oxime Hydroxylamine Reductive amination

  • Open Access

    Background of supported molecular matrix electrophoresis (SMME) and recent achievements in mucin analysis using SMME

    by Akihiko Kameyama

    グライコプロテオミクスの方法論開発に躓いたことを契機として,ムチンを分離分析するための方法である分子マトリックス電気泳動法(SMME)を開発した.本稿ではSMMEを応用した最近の研究成果として新しいO-型糖鎖遊離法である脱離オキシム化法およびSMMEで分離したムチンのレクチン染色による糖鎖解析について解説する.脱離オキシム化はヒドロキシルアミン存在下で塩基触媒によりムチンから糖鎖を遊離する方法で,遊離した糖鎖は直ちにオキシムへと変換される.オキシムは通常の糖鎖と同様に蛍光標識可能であり,蛍光検出器を用いた微量分析が可能となる.また,SMMEにより分離したムチンはレクチンで染色することができる.この方法により,粘表皮癌が分泌するMUC1にNeuAc α2–3Gal構造を含むコア2型糖鎖が多く存在することを明らかにした.SMMEを用いたムチン解析法は成熟してきており今後は医学系研究への応用が期待される.

  • Open Access

    Sialylation shapes mucus architecture inhibiting bacterial invasion in the colon

    by Mugen Taniguchi, Ryu Okumura, Takahisa Matsuzaki, Ayaka Nakatani, Kei Sakaki, Shota Okamoto, Airi Ishibashi, Haruka Tani, Momoka Horikiri, Naritaka Kobayashi, et al.


  • Open Access

    Expression and localisation of MUC1 modified with sialylated core-2 O-glycans in mucoepidermoid carcinoma

    by Takanori Sugiura, Kazuhiko Hashimoto, Kazutaka Kikuta, Ukei Anazawa, Takeshi Nomura, Akihiko Kameyama

    Mucoepidermoid carcinoma (MEC) is the most frequent of the rare salivary gland malignancies. We previously reported high expression of Mucin 1 (MUC1) modified with sialylated core-2 O-glycans in MEC by using tissue homogenates. In this study, we characterised glycan structures of MEC and identified the localisation of cells expressing these distinctive glycans on MUC1. Mucins were extracted from the frozen tissues of three patients with MEC, and normal salivary glands (NSGs) extracted from seven patients, separated by supported molecular matrix electrophoresis (SMME) and the membranes stained with various lectins. In addition, formalin-fixed, paraffin-embedded sections from three patients with MEC were subjected to immunohistochemistry (IHC) with various monoclonal antibodies and analysed for C2GnT-1 expression by in situ hybridisation (ISH). Lectin blotting of the SMME membranes revealed that glycans on MUC1 from MEC samples contained α2,3-linked sialic acid. In IHC, MUC1 was diffusely detected at MEC-affected regions but was specifically detected at apical membranes in NSGs. ISH showed that C2GnT-1 was expressed at the MUC1-positive in MEC-affected regions but not in the NSG. MEC cells produced MUC1 modified with α2,3-linked sialic acid-containing core-2 O-glycans. MUC1 containing these glycans deserves further study as a new potential diagnostic marker of MEC.


  • Open Access

    Expression and localisation of MUC1 modified with sialylated core-2 O-glycans in mucoepidermoid carcinoma

    by Takanori Sugiura, Kazuhiko Hashimoto, Kazutaka Kikuta, Ukei Anazawa, Takeshi Nomura, Akihiko Kameyama

    Mucoepidermoid carcinoma (MEC) is the most frequent of the rare salivary gland malignancies. We previously reported high expression of Mucin 1 (MUC1) modified with sialylated core-2 O-glycans in MEC by using tissue homogenates. In this study, we characterised glycan structures of MEC and identified the localisation of cells expressing these distinctive glycans on MUC1. Mucins were extracted from the frozen tissues of three patients with MEC, and normal salivary glands (NSGs) were extracted from seven patients, separated by supported molecular matrix electrophoresis (SMME) and the membranes stained with various lectins. In addition, formalin-fixed, paraffin-embedded sections from three patients with MEC were subjected to immunohistochemistry (IHC) with various monoclonal antibodies and analysed for C2GnT-1 expression by in situ hybridisation (ISH). Lectin blotting of the SMME membranes revealed that glycans on MUC1 from MEC samples contained α2,3-linked sialic acid. In IHC, MUC1 was diffusely detected at MEC-affected regions but was specifically detected at apical membranes in NSGs. ISH showed that C2GnT-1 was expressed at the MUC1-positive in MEC-affected regions but not in the NSG. Conclusion: MEC cells produced MUC1 modified with α2,3-linked sialic acid-containing core 2 O-glycans. MUC1 containing these glycans deserves further study as a new potential diagnostic marker of MEC. (200 words)

  • Open Access

    Characterization of tumor‑associated MUC1 and its glycans expressed in mucoepidermoid carcinoma

    by Eisaku Isaka, Takanori Sugiura, Kazuhiko Hashimoto, Kazutaka Kikuta, Ukei Anazawa, Takeshi Nomura, Akihiko Kameyama

    Mucoepidermoid carcinoma (MEC) is one of the most frequently misdiagnosed tumors. Glycans are modulated by malignant transformation. Mucin 1 (MUC1) is a mucin whose expression is upregulated in various tumors, including MEC, and it has previously been investigated as a diagnostic and prognostic tumor marker. The present study aimed to reveal the differences in the mucin glycans between MEC and normal salivary glands (NSGs) to discover novel diagnostic markers. Soluble fractions of salivary gland homogenate prepared from three MEC salivary glands and 7 NSGs were evaluated. Mucins in MEC and NSGs were separated using supported molecular matrix electrophoresis, and stained with Alcian blue and monoclonal antibodies. The glycans of the separated mucins were analyzed by mass spectrometry. MUC1 was found in MEC but not in NSGs, and almost all glycans of MUC1 in MEC were sialylated, whereas the glycans of mucins in NSGs were less sialylated. The core 2 type glycans, (Hex)2(HexNAc)2(NeuAc)1 and (Hex)2(HexNAc)2(NeuAc)2, were found to be significantly abundant glycans of MUC1 in MEC. MEC markedly produced MUC1 modified with sialylated core 2 glycans. These data were obtained from the soluble fractions of salivary gland homogenates. These findings provide a basis for the utilization of MUC1 as a serum diagnostic marker for the preoperative diagnosis of MEC.


  • Open Access

    Bmi-1 regulates mucin levels and mucin O-glycosylation in the submandibular gland of mice

    by Akihiko Kameyama, Risa Nishijima, Kimi Yamakoshi

    Mucins, the major components of salivary mucus, are large glycoproteins abundantly modified with O-glycans. Mucins present on the surface of oral tissues contribute greatly to the maintenance of oral hygiene by selectively adhering to the surfaces of microbes via mucin O-glycans. However, due to the complex physicochemical properties of mucins, there have been relatively few detailed analyses of the mechanisms controlling the expression of mucin genes and the glycosyltransferase genes involved in glycosylation. Analysis performed using supported molecular matrix electrophoresis, a methodology developed for mucin analysis, and knockout mice without the polycomb group protein Bmi-1 revealed that Bmi-1 regulates mucin levels in the submandibular gland by suppressing the expression of the mucin Smgc gene, and that Bmi-1 also regulates mucin O-glycosylation via suppression of the glycosyltransferase Gcnt3 gene in the submandibular gland.